Asia Pacific Pharmaceutical Continuous Manufacturing Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product; Application; End User; and Country- Product Image

Sale

Asia Pacific Pharmaceutical Continuous Manufacturing Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product; Application; End User; and Country

Report
168 Pages
August 2020
Region: Asia Pacific
The Insight Partners
ID: 5147223

UP TO €1439EUR$1,500USD£1,240GBP OFF until Jun 30^th 2024

Asia Pacific pharmaceutical continuous manufacturing market is anticipated to reach US$ 604.91 million by 2027 from US$ 274.10 million in 2019. The market is projected to grow at a CAGR of 10.5% from 2019 to 2027.

The pharmaceutical continuous manufacturing market is growing primarily due to the advantages offered by continuous manufacturing process. Restraining factors, such as advantages offered by continuous manufacturing process is likely to damage the growth of the market in the coming years. On the other hand, low R&D funding by government in developing economies is expected to have a positive impact on the growth of the Asia Pacific pharmaceutical continuous manufacturing market in the coming years.

Continuous manufacturing in the pharmaceutical industry is a result of advancements in technology with respect to the production techniques. The batch manufacturing method was traditionally followed in the pharmaceutical industry. However, the development in technology has accelerated mass production with improved quality, and it has addressed the several primary causes such as the recall of drugs and recalls. The pharmaceutical industry has recently begun to acknowledge the continuous manufacturing process as an option to improve and sustain manufacturing operations. More than 300 pharmaceutical continuous manufacturing companies are established in the regions such as Missouri, Columbia, Kansas, and Manhattan.

Batch manufacturing has been the most common and traditional mode of manufacturing in the pharmaceutical industry for more than a century. However, with the rising demand for biologics and increasing trend of contract manufacturing, the flexible manufacturing alternatives such as continuous manufacturing processes are being embraced and gaining importance in the recent years. The FDA is passing quick approvals to companies transitioning from batch production to continuous manufacturing procedures. Continuous pharmaceutical manufacturing involves end to end process from a drug taken from its base ingredients to final product with no need of halt or stop during the production. According to the Food and Drug Administration (FDA), the pharmaceutical manufacturing industry wastes up to50 billion every year on inefficient processes. Continuous manufacturing serves to be a potential solution for the same problem. Additionally, there are various other advantages offered by the continuous manufacturing process, such as time-efficiency, reduced energy needs, increased productivity, and reduction in overall wastage amounts. Further, the risk of human error is also reduced in the continuous manufacturing process due to the involvement of minimum number of people in the manufacturing process. Thus, the advantages offered by continuous manufacturing over batch manufacturing procedure are expected to drive the growth of the market over the coming years.

Considering the geographic and economical operations between Asian countries and China, the countries are expected to witness the challenge of COVID-19. The COVID-19 outbreak has severely affected all the businesses along with the supply chain disruptions and problems posed by the shortage of healthcare infrastructure in low-income countries. To reduce the spread of COVID-19, restrictive measures have been taken in South Korea, Malaysia, Singapore, the Philippines, and India. Domestic startups backed by international funding have already started witnessing back out from investors putting the development of the products in jeopardy.

In terms of product, the integrated systems segment accounted for the largest share of the Asia Pacific pharmaceutical continuous manufacturing market in 2019 and is estimated to mark the highest CAGR in the market during the forecast period, owing to the factors such as their easy availability and accessibility as well as higher adoption of these systems compared to the semi-continuous systems and the controls. Also, the convenience of use of upright freezers has led to its dominance during 2019 and is expected to witness similar trend over the coming years.

Centers For Disease Control And Prevention (CDC), Defense Research and Development Organization (DRDO), Rashtriya Swasthya Bima Yojna (RSBY), World Health Organization (WHO) are among the significant primary and secondary sources for pharmaceutical continuous manufacturing included in the report.

1. Introduction

1.1 Study Scope
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Pharmaceutical Continuous Manufacturing Market - By Product
1.3.2 Asia Pacific Pharmaceutical Continuous Manufacturing Market - By Application
1.3.3 Asia Pacific Pharmaceutical Continuous Manufacturing Market - By End User
1.3.4 Asia Pacific Pharmaceutical Continuous Manufacturing Market - By Country

2. Asia Pacific Pharmaceutical Continuous Manufacturing Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Pharmaceutical Continuous Manufacturing Market Landscape

4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific Pharmaceutical Continuous Manufacturing Market - Asia Pacific PEST Analysis
4.3 Expert Opinion

5. Asia Pacific Pharmaceutical Continuous Manufacturing - Key Market Dynamics

5.1 Key Market Drivers
5.1.1 Advantages Offered by Continuous Manufacturing Process
5.2 Key Restraints
5.2.1 Low R&D Funding by Government in Developing Economies
5.3 Key Market Opportunities
5.3.1 Emerging Markets
5.4 Future Trend
5.4.1 Increasing Adoption of Continuous Manufacturing in Pharmaceuticals
5.5 Impact Analysis

6. Pharmaceutical Continuous Manufacturing Market - Asia Pacific Analysis

6.1 Asia Pacific Pharmaceutical Continuous Manufacturing Market Revenue Forecasts and Analysis

7. Pharmaceutical Continuous Manufacturing Market Analysis - By Product

7.1 Overview
7.2 Pharmaceutical Continuous Manufacturing Market Share, by Product, 2019 and 2027 (%)
7.3 Integrated Systems
7.3.1 Overview
7.3.2 Integrated Systems: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.4 Semi-Continuous Systems
7.4.1 Overview
7.4.2 Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.4.3 Continuous Granulators
7.4.3.1 Overview
7.4.3.2 Continuous Granulators: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.4.4 Continuous Blenders
7.4.4.1 Overview
7.4.4.2 Continuous Blenders: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.4.5 Continuous Compressors
7.4.5.1 Overview
7.4.5.2 Continuous Compressors: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.4.6 Continuous Coaters
7.4.6.1 Overview
7.4.6.2 Continuous Coaters: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.4.7 Continuous Dryers
7.4.7.1 Overview
7.4.7.2 Continuous Dryers: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.4.8 Other Semi-Continuous Systems
7.4.8.1 Overview
7.4.8.2 Other Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.5 Controls
7.5.1 Overview
7.5.2 Controls: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)

8. Pharmaceutical Continuous Manufacturing Market- By Application

8.1 Overview
8.2 Pharmaceutical Continuous Manufacturing Market Share, by Application, 2019 and 2027 (%)
8.3 End Product Manufacturing
8.3.1 Overview
8.3.2 End Product Manufacturing: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
8.3.3 Solid Dosage Manufacturing
8.3.3.1 Overview
8.3.3.2 Solid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
8.3.4 Liquid Dosage Manufacturing
8.3.4.1 Overview
8.3.4.2 Liquid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
8.4 API Manufacturing
8.4.1 Overview
8.4.2 API Manufacturing: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)

9. Pharmaceutical Continuous Manufacturing Market - By End User

9.1 Overview
9.2 Pharmaceutical Continuous Manufacturing Market Share, by End User, 2019 and 2027 (%)
9.3 Full-Scale Manufacturing Companies
9.3.1 Overview
9.3.2 Full-Scale Manufacturing Companies: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
9.3.3 Pharmaceutical Companies
9.3.3.1 Overview
9.3.3.2 Pharmaceutical Companies: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
9.3.4 Contract Manufacturing Organizations
9.3.4.1 Overview
9.3.4.2 Contract Manufacturing Organizations: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
9.4 R&D Departments
9.4.1 Overview
9.4.2 R&D Departments: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
9.4.3 Contract Research Organizations
9.4.3.1 Overview
9.4.3.2 Contract Research Organizations: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
9.4.4 Research Institutes
9.4.4.1 Overview
9.4.4.2 Research Institutes: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)

10. Pharmaceutical Continuous Manufacturing Market Revenue and Forecasts To 2027 - Geographical Analysis

10.1 Asia Pacific Pharmaceutical Continuous Manufacturing Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.1.2.1 Asia Pacific: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.1.3 Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.1.3.1 Asia Pacific: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.1.4 Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.1.4.1 Asia Pacific: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.1.4.2 Asia Pacific: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.1.5 Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)
10.1.6 China: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.6.1 China: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.1.6.1.1 China: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.1.6.2 China: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.1.6.2.1 China: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.1.6.3 China: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.1.6.3.1 China: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.1.6.3.2 China: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.1.7 Japan: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Japan: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.1.7.1.1 Japan: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.1.7.2 Japan: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.1.7.2.1 Japan: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.1.7.3 Japan: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.1.7.3.1 Japan: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.1.7.3.2 Japan: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.1.8 India: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.1 India: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.2 India: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.1.8.2.1 India: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.1.8.3 India: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.1.8.3.1 India: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.1.8.4 India: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.1.8.4.1 India: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.1.8.4.2 India: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.1.9 South Korea: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.1 South Korea: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.2 South Korea: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.1.9.2.1 South Korea: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.1.9.3 South Korea: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.1.9.3.1 South Korea: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.1.9.4 South Korea: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.1.9.4.1 South Korea: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.1.9.4.2 South Korea: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.1.10 Australia: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.10.1 Australia: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.10.2 Australia: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.1.10.2.1 Australia: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.1.10.3 Australia: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.1.10.3.1 Australia: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.1.10.4 Australia: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.1.10.4.1 Australia: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.1.10.4.2 Australia: R&D Departments Market, by Type, 2018-2027 (USD Million)

11. Impact of COVID-19 Pandemic on Global Pharmaceutical Continuous Manufacturing Market

11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic

12. Company Profiles

12.1 Powrex Corp
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 ACG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Cadmach Machinery Co. Pvt. Ltd.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Hosokawa Micron Group
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 THERMO FISHER SCIENTIFIC INC.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

13. Appendix

13.1 About the Publisher
13.2 Glossary of Terms

List of Tables

Table 1. Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 2. Asia Pacific: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 3. Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 4. Asia Pacific: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 5. Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 6. Asia Pacific: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 7. Asia Pacific: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 8. China: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 9. China: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 10. China: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 11. China: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 12. China: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. China: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 14. China: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 15. Japan: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 16. Japan: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 17. Japan: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 18. Japan: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 19. Japan: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 20. Japan: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 21. Japan: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 22. India: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 23. India: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 24. India: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 25. India: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 26. India: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 27. India: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 28. India: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 29. South Korea: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 30. South Korea: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 31. South Korea: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 32. South Korea: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 33. South Korea: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 34. South Korea: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 35. South Korea: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 36. Australia: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 37. Australia: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 38. Australia: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 39. Australia: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 40. Australia: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 41. Australia: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 42. Australia: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 43. Glossary of Terms, Asia Pacific Pharmaceutical Continuous Manufacturing Market

List of Figures

Figure 1. Pharmaceutical Continuous Manufacturing Market Segmentation
Figure 2. Asia Pacific Pharmaceutical Continuous Manufacturing Market Overview
Figure 3. The Integrated Systems Segment Held Largest Share of Product Segment in Pharmaceutical Continuous Manufacturing Market
Figure 4. Japan Is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Asia Pacific Pharmaceutical Continuous Manufacturing Market- Leading Country Markets (US$ Mn)
Figure 6. Asia Pacific Pharmaceutical Continuous Manufacturing Market - Asia Pacific PEST Analysis
Figure 7. Pharmaceutical Continuous Manufacturing Market Impact Analysis of Drivers and Restraints
Figure 8. Asia Pacific Pharmaceutical Continuous Manufacturing Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Pharmaceutical Continuous Manufacturing Market Share, by Product, 2019 and 2027 (%)
Figure 10. Integrated Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 11. Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 12. Continuous Granulators: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 13. Continuous Blenders: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 14. Continuous Compressors: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 15. Continuous Coaters: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 16. Continuous Dryers: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 17. Other Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 18. Controls: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 19. Pharmaceutical Continuous Manufacturing Market Share, by Application, 2019 and 2027 (%)
Figure 20. End Product Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 21. Solid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 22. Liquid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 23. API Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 24. Pharmaceutical Continuous Manufacturing Market Share, by End User, 2019 and 2027 (%)
Figure 25. Full-Scale Manufacturing Companies: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 26. Pharmaceutical Companies: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 27. Contract Manufacturing Organizations: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 28. R&D Departments: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 29. Contract Research Organizations: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 30. Research Institutes: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 31. Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Key Country – Revenue (2019) (USD Million)
Figure 32. Asia Pacific Pharmaceutical Continuous Manufacturing Market Revenue and Forecast to 2027 (USD Million)
Figure 33. China: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 34. Japan: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. India: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. South Korea: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. Australia: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Powrex Corp
ACG
Cadmach Machinery Co. Pvt. Ltd
Hosokawa Micron Group,
THERMO FISHER SCIENTIFIC INC.

PURCHASE OPTIONS

Single User License PDF

Site License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2015EUR$2,100USD£1,735GBP €2878EUR$3,000USD£2,479GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€2687EUR$2,800USD£2,314GBP €3838EUR$4,000USD£3,306GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3358EUR$3,500USD£2,892GBP €4797EUR$5,000USD£4,132GBP

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Global Pharmaceutical Continuous Manufacturing Market by Product (Integrated Systems, Semi-Continuous Systems), Distribution (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Application, End User - Forecast 2024-2030

Pharmaceutical Continuous Manufacturing Global Market Report 2024

Pharmaceutical Continuous Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Global Pharmaceutical Continuous Manufacturing Market 2024-2028

Distributed Control System Market by Component (Hardware, Software, Services), Application (Continuous, Batch-Oriented), End-user (Oil & Gas, Power Generation, Chemical, Food & Beverages, Pharmaceutical, Metal & Mining), Region - Global Forecast to 2028